NPM1 and acute myeloid leukemia: DNMT3A and NPM1 are 2 of the most frequently mutated genes in AML, each affecting 20%–30% of patients; these co-occur more frequently than expected by chance, with approximately 15% of patients with AML having mutations in both genes (7–9).